Hai Zheng Pharmaceutical: plan to repurchase shares with 50 million to 100 million yuan.

Haizheng Pharmaceuticals announced that the company plans to repurchase shares with a total amount not less than 50 million yuan and not more than 100 million yuan, at a repurchase price not exceeding 13 yuan per share. The repurchased shares will be used entirely for the implementation of an employee stock ownership plan, with an estimated repurchase quantity of 3.8462 to 7.6923 million shares, accounting for 0.32% to 0.64% of the company's total share capital. The repurchase period is within 12 months from the date of approval by the board of directors, with funds coming from the company's own capital. The repurchase aims to improve long-term incentive mechanisms, enhance investor confidence, and promote the company's long-term development. The company will implement the repurchase opportunistically during the repurchase period based on market conditions, and will fulfill information disclosure obligations in a timely manner according to progress.